Home › Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
 

Keywords :   


Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis

2013-11-04 12:23:21| Biotech - Topix.net

Active Biotech announced today that its partner Teva Pharmaceutical Industries Ltd. will initiate a further clinical trial, LIBRETTO, to evaluate the efficacy, safety and tolerability of two doses of oral laquinimod , compared to interferon beta-1a, in patients with relapsing remitting multiple sclerosis.

Tags: partner active multiple trial

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
28.09Hurricane Isaac Public Advisory Number 12
28.09Summary for Hurricane Isaac (AT5/AL102024)
More »